glp-1 for dementia Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and in Diabetes Mellitus Prevention of Dementia with GLP-1
Description
The new findings add to a growing body of research suggesting that GLP-1 receptor agonists may influence mental health as well as metabolic health
WNT signalling is both an inducer and effector of glucagon-like peptide-1
Carol Saffran started taking Ozempic a year ago to regulate her blood sugar after other medications were ineffective
Dipeptidyl peptidase 4 inhibitor sitagliptin maintains -cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study
The growing demand for self-injection devices cannot be met with traditional solutions alone
